InhaleRx Ltd News

InhaleRx Ltd: Half Yearly Report and Accounts

Aug 30 16:37

InhaleRx Ltd: Jun24 Quarterly Activities Report

Jul 31 17:15

InhaleRx Ltd: Jun24 Appendix 4C Cash Flow Report

Jul 31 16:21

InhaleRx Ltd: Live Investor Webinar

Jul 25 11:59

InhaleRx Ltd: IRX616a IND Application Outcome

Jul 5 14:20

InhaleRx Ltd: Final Clinical Study Report Received, Phase 1 IRX-211

Jul 3 08:48

InhaleRx Ltd: Change of Director's Interest Notice - Sean Williams

Jun 6 13:42

InhaleRx Ltd: Notification regarding unquoted securities - IRX

Jun 3 15:22

InhaleRx Ltd: AGM Results

May 31 06:37

InhaleRx Ltd: 2024 AGM Slides

May 30 13:54

InhaleRx Ltd: Significant Milestone - IND submitted to the FDA for IRX616a

May 30 13:08

InhaleRx Ltd: Mar24 Appendix 4C Cash Flow Report

Apr 30 14:31

InhaleRx Ltd: Mar24 Quarterly Activities Report

Apr 30 14:30

InhaleRx Ltd: AGM Access Letter

Apr 30 07:16

InhaleRx Ltd: AGM Sample Proxy Form

Apr 30 07:16

InhaleRx Ltd: Notice of Annual General Meeting

Apr 30 07:16

InhaleRx Ltd: Change of Registered Office Address

Apr 18 11:39

InhaleRx Ltd: Proposed issue of securities - IRX

Mar 28 15:51

InhaleRx Ltd: Appendix 4G

Mar 28 13:36

InhaleRx Ltd: Corporate Governance Statement and Appendix 4G

Mar 28 12:42